4-Chlorocinnamic acid
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


4-Chlorocinnamic acid
Description :
4-Chlorocinnamic acid is a derivative of Cinnamic acid (HY-N0610A) . 4-Chlorocinnamic acid inhibits the monophenolase and diphenolase activities of mushroom tyrosinase with IC50 values of 0.477 mM and 0.229 mM, respectively. 4-Chlorocinnamic acid inhibits the mycelial growth of Colletotrichum gloeosporioides. 4-Chlorocinnamic acid exhibits anticonvulsant activity against acute epilepsy induced by pentylenetetrazol[1][2][3][4].UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
Bacterial; Drug Derivative; Fungal; TyrosinaseType :
Reference compoundRelated Pathways :
Anti-infection; Metabolic Enzyme/Protease; OthersApplications :
COVID-19-immunoregulationField of Research :
Infection; Neurological DiseaseAssay Protocol :
https://www.medchemexpress.com/4-chlorocinnamic-acid.htmlPurity :
99.98Solubility :
DMSO : 100 mg/mL (ultrasonic)Smiles :
O=C(O)/C=C/C1=CC=C(Cl)C=C1Molecular Formula :
C9H7ClO2Molecular Weight :
182.61Precautions :
H302, H315, H319, H335References & Citations :
[1]Cui Y, et al. Inhibition kinetics and molecular simulation of p-substituted cinnamic acid derivatives on tyrosinase. Int J Biol Macromol. 2017 Feb;95:1289-1297.|[2]Silva RHN, et al. Antimicrobial Activity of 4-Chlorocinnamic Acid Derivatives. Biomed Res Int. 2019 Apr 23;2019:3941242.|[3]Kátia Aparecida de Siqueira, et al. Isolation of 4-chlorocinnamic acid from Streptomyces griseocarneus R132, and its inhibition activity against sweet pepper postharvest anthracnose. Biocontrol Science and Technology. Volume 32, 2022-Issue 6|[4]Cuan Y, et al. Anticonvulsant Activity of Halogen-Substituted Cinnamic Acid Derivatives and Their Effects on Glycosylation of PTZ-Induced Chronic Epilepsy in Mice. Molecules. 2017 Dec 29;23 (1) :76.Shipping Conditions :
Room TemperatureStorage Conditions :
Store at room temperature 3 yearsScientific Category :
Reference compound1Clinical Information :
No Development ReportedCAS Number :
[1615-02-7]

